Total Payments
$14,046
2024 Payments
$2,650
Companies
43
Transactions
667
Medicare Patients
6,842
Medicare Billing
$951,845
Payment Breakdown by Category
Food & Beverage$13,558 (96.5%)
Education$487.74 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,558 | 657 | 96.5% |
| Education | $487.74 | 10 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,078 | 158 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,959 | 143 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,353 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $621.37 | 37 | $0 (2024) |
| Mylan Specialty L.P. | $565.92 | 27 | $0 (2024) |
| Genentech USA, Inc. | $437.77 | 22 | $0 (2019) |
| Insmed, Inc. | $416.21 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $407.88 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $390.55 | 15 | $0 (2024) |
| GENZYME CORPORATION | $366.75 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,650 | 109 | AstraZeneca Pharmaceuticals LP ($570.95) |
| 2023 | $2,007 | 89 | GlaxoSmithKline, LLC. ($586.86) |
| 2022 | $2,488 | 98 | AstraZeneca Pharmaceuticals LP ($599.96) |
| 2021 | $1,571 | 89 | AstraZeneca Pharmaceuticals LP ($376.53) |
| 2020 | $749.06 | 33 | GlaxoSmithKline, LLC. ($265.07) |
| 2019 | $1,637 | 81 | GlaxoSmithKline, LLC. ($302.85) |
| 2018 | $1,318 | 78 | GlaxoSmithKline, LLC. ($260.67) |
| 2017 | $1,626 | 90 | GlaxoSmithKline, LLC. ($397.98) |
All Payment Transactions
667 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/11/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Immunology and Neurology | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.86 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: Oncology | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $10.86 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,524 | 2,567 | $441,393 | $166,897 |
| 2022 | 12 | 1,851 | 3,500 | $615,594 | $223,180 |
| 2021 | 13 | 1,969 | 4,123 | $750,596 | $284,257 |
| 2020 | 14 | 1,498 | 3,727 | $705,224 | $277,511 |
Total Patients
6,842
Total Services
13,917
Medicare Billing
$951,845
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 232 | 829 | $116,060 | $49,921 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 423 | $95,175 | $36,910 | 38.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 273 | $54,327 | $25,202 | 46.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 131 | 138 | $45,540 | $17,825 | 39.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 248 | 277 | $41,550 | $10,260 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $20,460 | $7,153 | 35.0% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 83 | 93 | $13,950 | $5,484 | 39.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 252 | 282 | $26,790 | $5,092 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 51 | $9,180 | $3,289 | 35.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 104 | 108 | $10,260 | $2,474 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $4,485 | $1,918 | 42.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,616 | $1,369 | 37.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 339 | 1,352 | $189,280 | $72,740 | 38.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 104 | 506 | $100,694 | $39,443 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 274 | 403 | $90,675 | $35,673 | 39.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 214 | 224 | $73,920 | $34,150 | 46.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 269 | 308 | $40,215 | $12,141 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 92 | 92 | $30,360 | $9,891 | 32.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 278 | 319 | $30,305 | $5,936 | 19.6% |
| 71250 | Ct scan of chest without contrast | Office | 2022 | 81 | 88 | $27,150 | $5,288 | 19.5% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 100 | 107 | $10,165 | $2,519 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 29 | $5,220 | $1,887 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $5,650 | $1,824 | 32.3% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2022 | 18 | 18 | $10,800 | $1,494 | 13.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 17 | 17 | $680.00 | $118.97 | 17.5% |
About Dr. Scott Pethke, M.D
Dr. Scott Pethke, M.D is a Critical Care Medicine healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609828094.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Pethke, M.D has received a total of $14,046 in payments from pharmaceutical and medical device companies, with $2,650 received in 2024. These payments were reported across 667 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($13,558).
As a Medicare-enrolled provider, Pethke has provided services to 6,842 Medicare beneficiaries, totaling 13,917 services with total Medicare billing of $951,845. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Augusta, GA
- Active Since 05/16/2006
- Last Updated 07/31/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1609828094
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,174
- DUPIXENT (Biological) $814.43
- FASENRA (Biological) $771.08
- OPSUMIT (Drug) $665.84
- NUCALA (Biological) $593.07
- UPTRAVI (Drug) $570.99
- TEZSPIRE (Biological) $494.88
- BREZTRI (Drug) $453.10
- Arikayce (Drug) $416.21
- SYMBICORT (Drug) $396.06
- BEVESPI AEROSPHERE (Drug) $374.41
- ANORO (Drug) $366.70
- AREXVY (Drug) $352.63
- ACTHAR (Biological) $331.48
- Esbriet (Biological) $287.19
- AIRSUPRA (Drug) $285.98
- STIOLTO RESPIMAT (Drug) $284.79
- Adempas (Drug) $272.95
- OFEV (Drug) $227.07
- YUPELRI (Drug) $195.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Augusta
Bruce Friedman, M.d, M.D
Critical Care Medicine — Payments: $1.0M
Critical Care Medicine $1.0M
Dr. Carmel Joseph, Md, MD
Critical Care Medicine — Payments: $44,125
Critical Care Medicine $44,125
Shaheen Islam, Mbbs, MBBS
Critical Care Medicine — Payments: $21,874
Critical Care Medicine $21,874
Dr. Varsha Kulkarni, M.d, M.D
Critical Care Medicine — Payments: $14,293
Critical Care Medicine $14,293
Brent Bermingham, Md, MD
Critical Care Medicine — Payments: $5,374
Critical Care Medicine $5,374
Dr. Anthony Ramage, Do, DO
Critical Care Medicine — Payments: $2,621
Critical Care Medicine $2,621